WWW.NATURE.COM/NATURE
This press release is copyright Nature.
Editorial contacts: While the best contacts for stories will always be the authors themselves, in some cases the Nature editor who handled the paper will be available for comment if an author is unobtainable. Editors are contactable via Ruth Francis on +44 20 7843 4562. Feel free to get in touch with Nature's press contacts in London, Washington and Tokyo (as listed at the end of this release) with any general editorial inquiry.
Warning: This document, and the Nature papers to which it refers, may contain information that is price sensitive (as legally defined, for example, in the UK Criminal Justice Act 1993 Part V) with respect to publicly quoted companies. Anyone dealing in securities using information contained in this document or in advanced copies of Nature’s content may be guilty of insider trading under the US Securities Exchange Act of 1934.
The Nature journals press site is at http://press.nature.com
PICTURES: While we are happy for images from Nature to be reproduced for the purposes of contemporaneous news reporting, you must also seek permission from the copyright holder (if named) or author of the research paper in question (if not).
HYPE: We take great care not to hype the papers mentioned on our press releases, but are sometimes accused of doing so. If you ever consider that a story has been hyped, please do not hesitate to contact us at [email protected], citing the specific example.
PLEASE CITE NATURE AND OUR WEBSITE www.nature.com/nature AS THE SOURCE OF THE FOLLOWING ITEMS. IF PUBLISHING ONLINE, PLEASE CARRY A HYPERLINK TO http://www.nature.com/nature
Cell biology: New technique for generating human embryonic stem cell lines (AOP)
DOI: 10.1038/nature05142
By plucking single cells from human embryos, Robert Lanza and his colleagues have been able to generate new lines of cultured human embryonic stem (ES) cells. The advance, to be published online this week by Nature, could allow scientists to pursue human ES cell studies but avoid the controversial destruction of human embryos.
Embryonic stem cells are typically grown by extracting a mass of cells from an embryo after it forms a hollow blastocyst, destroying the embryo in the process. But last year, Lanza's team showed that they could instead remove a single cell from an earlier stage mouse embryo and amplify it into a colony of ES cells in culture. This procedure is similar to that used during in vitro fertilization (IVF) to remove a single cell for preimplantation genetic diagnosis.
In the current study, human embryos were biopsied multiple times and single cells were used to generate human ES cell lines. They obtained two stable human ES cell lines that, according to their experiments, behave like conventional ES cell lines. The technique could allow ES cell lines to be grown from cells routinely removed for preimplantation genetic diagnosis.
CONTACT:
Robert Lanza (Advanced Cell Technology, Worcester MA, USA)
Tel: +1 508 756 1212; E-mail: [email protected]
About Nature Publishing Group
Nature Publishing Group (NPG) is a division of Macmillan Publishers Ltd, dedicated to serving the academic, professional scientific and medical communities. NPG's flagship title, Nature, was first published in 1869. Other publications include Nature research journals, Nature Reviews, Nature Clinical Practice and a range of prestigious academic journals including society-owned publications. NPG also provides news content through [email protected] and scientific career information through Naturejobs.
NPG is a global company with headquarters in London and offices in New York, San Francisco, Washington DC, Boston, Tokyo, Paris, Munich, Hong Kong, Melbourne, Delhi, Mexico City and Basingstoke. For more information, please go to <www.nature.com>.
